ADUS:NSD-Addus HomeCare Corporation (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 121.33

Change

+1.06 (+0.88)%

Market Cap

USD 1.90B

Volume

0.10M

Average Target Price

USD 115.00 (-5.22%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment's services include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of June 30, 2020, the company served consumers through 190 offices located in 25 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-01-14 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys, Inc

-1.82 (-0.63%)

USD9.50B 58.03 39.29
LHCG LHC Group, Inc

-2.01 (-0.94%)

USD6.75B 64.91 31.67
ACHC Acadia Healthcare Company, Inc

-0.64 (-1.24%)

USD4.58B 45.45 17.18
ENSG The Ensign Group, Inc

+1.22 (+1.46%)

USD4.53B 30.70 20.68
HCSG Healthcare Services Group, Inc

+0.28 (+0.87%)

USD2.39B 26.69 15.35
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
PNTG The Pennant Group, Inc

+1.62 (+2.63%)

USD1.77B 188.80 107.49
SGRY Surgery Partners, Inc

-0.54 (-1.76%)

USD1.56B 63.00 17.17
TVTY Tivity Health, Inc

+0.43 (+2.07%)

USD1.01B 8.78 N/A
AMEH Apollo Medical Holdings, Inc

+0.41 (+1.92%)

USD0.78B 22.16 4.11

ETFs Containing ADUS

Symbol Name Weight Mer Price(Change) Market Cap
DWMC AdvisorShares Dorsey Wrig.. 0.00 % 1.25 %

+0.65 (+2.02%)

USD2.90M

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.62% 38% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.62% 38% F 39% F
Trailing 12 Months  
Capital Gain 23.81% 38% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.81% 38% F 63% D
Trailing 5 Years  
Capital Gain 490.70% 80% B- 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 490.70% 80% B- 92% A-
Average Annual (5 Year Horizon)  
Capital Gain 45.18% 69% D+ 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.18% 69% D+ 89% B+
Risk Return Profile  
Volatility (Standard Deviation) 32.75% 63% D 44% F
Risk Adjusted Return 137.97% 94% A 97% A+
Market Capitalization 1.90B 69% D+ 73% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 54.08 50% F 22% F
Price/Book Ratio 3.77 69% D+ 40% F
Price / Cash Flow Ratio 158.19 13% F 3% F
EV/EBITDA 30.59 42% F 29% F
Management Effectiveness  
Return on Equity 7.25% 56% F 69% D+
Return on Invested Capital 6.61% 56% F 67% D+
Return on Assets 5.02% 63% D 84% B
Debt to Equity Ratio 12.44% 86% B 72% C-
Technical Ratios  
Short Ratio 2.53 75% C 52% F
Short Percent 2.02% 80% B- 63% D
Beta 0.63 64% D 81% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector